- Author
- Walter Veit, Jonathan Anomaly, Nicholas Agar, Peter Singer, Diana S. Fleischman and Francesca Minerva (UGent)
- Organization
- Abstract
- In recent years, bioethical discourse around the topic of 'genetic enhancement' has become increasingly politicized. We fear there is too much focus on the semantic question of whether we should call particular practices and emerging bio-technologies such as CRISPR 'eugenics', rather than the more important question of how we should view them from the perspective of ethics and policy. Here, we address the question of whether 'eugenics' can be defended and how proponents and critics of enhancement should engage with each other.
- Keywords
- Ethics, Eugenics, Enhancement, Human enhancement, Embryo selection, Gene, editing, CRISPR
Downloads
-
Publisher version.pdf
- full text (Published version)
- |
- open access
- |
- |
- 505.81 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8743411
- MLA
- Veit, Walter, et al. “Can ‘eugenics’ Be Defended?” MONASH BIOETHICS REVIEW, vol. 39, no. 1, 2021, pp. 60–67, doi:10.1007/s40592-021-00129-1.
- APA
- Veit, W., Anomaly, J., Agar, N., Singer, P., Fleischman, D. S., & Minerva, F. (2021). Can “eugenics” be defended? https://doi.org/10.1007/s40592-021-00129-1
- Chicago author-date
- Veit, Walter, Jonathan Anomaly, Nicholas Agar, Peter Singer, Diana S. Fleischman, and Francesca Minerva. 2021. “Can ‘eugenics’ Be Defended?” MONASH BIOETHICS REVIEW. https://doi.org/10.1007/s40592-021-00129-1.
- Chicago author-date (all authors)
- Veit, Walter, Jonathan Anomaly, Nicholas Agar, Peter Singer, Diana S. Fleischman, and Francesca Minerva. 2021. “Can ‘eugenics’ Be Defended?” MONASH BIOETHICS REVIEW. doi:10.1007/s40592-021-00129-1.
- Vancouver
- 1.Veit W, Anomaly J, Agar N, Singer P, Fleischman DS, Minerva F. Can “eugenics” be defended? Vol. 39, MONASH BIOETHICS REVIEW. 2021. p. 60–7.
- IEEE
- [1]W. Veit, J. Anomaly, N. Agar, P. Singer, D. S. Fleischman, and F. Minerva, “Can ‘eugenics’ be defended?,” MONASH BIOETHICS REVIEW, vol. 39, no. 1. pp. 60–67, 2021.
@misc{8743411,
abstract = {{In recent years, bioethical discourse around the topic of 'genetic enhancement' has become increasingly politicized. We fear there is too much focus on the semantic question of whether we should call particular practices and emerging bio-technologies such as CRISPR 'eugenics', rather than the more important question of how we should view them from the perspective of ethics and policy. Here, we address the question of whether 'eugenics' can be defended and how proponents and critics of enhancement should engage with each other.}},
author = {{Veit, Walter and Anomaly, Jonathan and Agar, Nicholas and Singer, Peter and Fleischman, Diana S. and Minerva, Francesca}},
issn = {{1321-2753}},
keywords = {{Ethics,Eugenics,Enhancement,Human enhancement,Embryo selection,Gene,editing,CRISPR}},
language = {{eng}},
number = {{1}},
pages = {{60--67}},
series = {{MONASH BIOETHICS REVIEW}},
title = {{Can 'eugenics' be defended?}},
url = {{http://dx.doi.org/10.1007/s40592-021-00129-1}},
volume = {{39}},
year = {{2021}},
}
- Altmetric
- View in Altmetric